Nyvepria Injection, Solution
Product Images NDC 0069-0324
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 20 technical images submitted to the FDA as part of the official labeling for Nyvepria (NDC 0069-0324). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Pfizer Laboratories Div Pfizer Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Logo (Nyvepria 02)
This is a very short and incomplete text, but based on what is visible, it appears to be the name of a pharmaceutical company or product line focused on oncology. It is likely referring to the drug "P zer" which may have applications in cancer treatment. However, without more context or information, it is impossible to provide a more detailed or accurate description. *
Figure (Nyvepria 03)
Figure (Nyvepria 04)
Figure (Nyvepria 04a)
Figure (Nyvepria 05)
Figure (Nyvepria 06)
This text appears to be a list of medical items or equipment. The first item is a "Pre-filled syringe." The second item is an "adhesive bandage," which is likely a small bandage designed to stick to the skin. The third item is a "sharps disposal container," which suggests a container for properly disposing of sharp medical equipment such as needles or scalpels.*
Figure (Nyvepria 07)
Figure (Nyvepria 08)
Figure (Nyvepria 09)
Figure (Nyvepria 10)
Figure (Nyvepria 11)
Figure (Nyvepria 12)
Figure (Nyvepria 13)
Figure (Nyvepria 14)
Figure (Nyvepria 15)
Figure (Nyvepria 16)
Principal Display Panel (6 mg/0.6 mL Syringe Label)
Nyvepria® is a prescription drug that is administered through subcutaneous injection. It is manufactured by a company called Lake Forest and is licensed in the US under License No. 1974. It comes in a prefilled syringe with a needle guard and contains 6 mg/0.6 mL of pegfilgrastim-apgf. The production data indicates that it is varnish-free.*
Principal Display Panel (6 mg/0.6 mL Syringe Carton)
Principal Display Panel (6 mg/0.6 mL Syringe Carton)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.